For the Inventor, By the Inventor

Enter assignee name

Cambridge, MA, United States of America

I2o Therapeutics, Inc.

USPTO Granted Patents = 8

EPO Patents = 2

Trademarks = 2

Forward Citations = 2

Loading Chart...

Loading Chart...

18 inventors (with patents filed for the assignee):

William Blackwell (4 out of 7 patents)

Ved P Srivastava (4 out of 8 patents)

Kelly Ibsen (3 out of 5 patents)

4. Tyler Brown (3 out of 5 patents)

5. Mark A Paulik (2 out of 4 patents)

6. James M Way (2 out of 3 patents)

7. Thomas R Alessi (1 out of 20 patents)

8. Robert Neil Hunter, Iii (1 out of 4 patents)

9. Steven Thomas Dock (1 out of 4 patents)

10. Andrew A Young (1 out of 68 patents)

11. Kenneth Luskey (1 out of 1 patent)

12. Jay S Smith (7 patents)

13. Michael R Cole (28 patents)

14. Scott D Lautenbach (28 patents)

15. Amy K Whitson (5 patents)

8 patents: Sort by Forward Citations

1. 12350320 - Compositions comprising pharmaceutically acceptable salts of glucagon-like peptide-1 analogs and pharmaceutically acceptable salts of amylin analogs, and uses thereof (2025-07-08),

2. 12337029 - Compositions comprising pharmaceutically acceptable salts of amylin analogs and uses thereof (2025-06-24),

3. 12233111 - Compositions comprising pharmaceutically acceptable salts of glucagon-like peptide-1 analogs and uses thereof (2025-02-25),

4. 12122816 - Long acting peptide tyrosine tyrosine (PYY) analogs and methods of use (2024-10-22),

5. 12084485 - Long acting glucagon like polypeptide-1 (GLP-1) receptor agonists and methods of use (2024-09-10),

6. 12042557 - Rapid establishment and/or termination of substantial steady-state drug delivery (2024-07-23),

7. 12018059 - Human amylin analog polypeptides and methods of use (2024-06-25),

8. 11840559 - Glucagon-receptor selective polypeptides and methods of use thereof (2023-12-12),

I2o Therapeutics, Inc. is a biotechnology company focused on developing innovative drug delivery solutions for the treatment of various diseases. The company's proprietary platform technology enables the targeted delivery of therapeutics to specific tissues or cells, improving efficacy and reducing side effects. With a robust pipeline of novel drug candidates, I2o Therapeutics is at the forefront of advancing healthcare through cutting-edge research and development.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

8 Patents

#243 in Cambridge, MA

#2,031 in Massachusetts

#34,831 in US

Cambridge, MA, United States of America

I2o Therapeutics, Inc.

Forward Citations = 2

18 inventors:

William Blackwell (4 out of 7 patents)

Ved P Srivastava (4 out of 8 patents)

Kelly Ibsen (3 out of 5 patents)

4. Tyler Brown (3 out of 5 patents)

5. Mark A Paulik (2 out of 4 patents)

Please report any incorrect information to support@idiyas.com

Loading…